EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (Apis mellifera), as a Promising Prototype for New Medicines: A Narrative Review

William Gustavo Lima iD, Julio Cesar Moreira Brito, Rodrigo Moreira Verly iD, Maria Elena de Lima iD

Toxins · 02.01.2024 · 16 (1) · 24

DOI: 10.3390/toxins16010024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 02.01.2024. Verfasst von William Gustavo Lima und 3 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-Graduação Stricto Sensu em Medicina e Biomedicina, Faculdade de Saúde da Santa Casa de Belo Horizonte, Avenida dos Andradas, 2688, Sa…. Hauptthemen laut MEDLINE: Peptides, Honey. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The jelleine family is a group of four peptides (jelleines I–IV) originally isolated from the royal jelly of honey bee (Apis mellifera), but later detected in some honey samples. These oligopeptides are composed of 8–9 amino acid residues, positively charged (+2 to +3 at pH 7.2), including 38–50% of hydrophobic residues and a carboxamide C-terminus. Jelleines, generated by processing of the C-terminal region of major royal jelly proteins 1 (MRJP-1), play an important biological role in royal jelly conservation as well as in protecting bee larvae from potential pathogens. Therefore, these molecules present numerous benefits for human health, including therapeutic purposes as shown in preclinical studies. In this review, we aimed to evaluate the biological effects of jelleines in addition to characterising their toxicities and stabilities. Jelleines I–III have promising antimicrobial activity and low toxicity (LD50 > 1000 mg/Kg). However, jelleine-IV has not shown relevant biological potential. Jelleine-I, but not the other analogues, also has antiparasitic, healing, and pro-coagulant activities in addition to indirectly modulating tumor cell growth and controlling the inflammatory process. Although it is sensitive to hydrolysis by proteases, the addition of halogens increases the chemical stability of these molecules. Thus, these results suggest that jelleines, especially jelleine-I, are a potential target for the development of new, effective and safe therapeutic molecules for clinical use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesHoneyHumansBeesAnimalsFatty AcidsLarvaRoyal Jelly

Stichwörter der Autor:innen

anti-inflammatoryanti-leishmaniaantibacterialantifungalhealingjelleine-Iroyal jelly

Substanzen

PeptidesFatty AcidsRoyal Jelly

Autor:innen und Institutionen

  • Programa de Pós-Graduação Stricto Sensu em Medicina e Biomedicina, Faculdade de Saúde da Santa Casa de Belo Horizonte, Avenida dos Andradas, 2688, Santa Efigênia, Belo Horizonte 30110-005, MG, Brazil.
  • Fundação Ezequiel Dias (FUNED), Rua Conde Pereira Carneiro, 8, Gameleira, Belo Horizonte 30510-010, MG, Brazil.
  • Departamento de Química, Faculdade de Ciências Exatas, Universidade Federal dos Vales do Jequitinhonha e Mucuri, Rodovia MGT 367, 5000, Auto da Jacuba, Diamantina 39100-000, MG, Brazil.

ORCID-Profile: William Gustavo Lima, Rodrigo Moreira Verly, Maria Elena de Lima

Förderung

  • National Council for Scientific and Technological Development
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
  • Fundação de Auxílio à Pesquisa do Estado de Minas Gerais (FAPEMIG)

Zitieren

APA

Lima, W. G., Brito, J. C. M., Verly, R. M., & Lima, M. E. (2024). Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (Apis mellifera), as a Promising Prototype for New Medicines: A Narrative Review. Toxins, 16(1), 24. https://doi.org/10.3390/toxins16010024

Vancouver

Lima WG, Brito JCM, Verly RM, Lima ME. Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (Apis mellifera), as a Promising Prototype for New Medicines: A Narrative Review. Toxins. 2024;16(1):24. doi:10.3390/toxins16010024

BibTeX
@article{Lima2024,
  author = {Lima, William Gustavo and Brito, Julio Cesar Moreira and Verly, Rodrigo Moreira and Lima, Maria Elena de},
  title = {Jelleine, a Family of Peptides Isolated from the Royal Jelly of the Honey Bees (Apis mellifera), as a Promising Prototype for New Medicines: A Narrative Review},
  journal = {Toxins},
  year = {2024},
  volume = {16},
  number = {1},
  pages = {24},
  doi = {10.3390/toxins16010024}
}
Kostenlos starten →